Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M621Revenue $M1.1Net Margin (%)-2,852.7Z-Score26.9
Enterprise Value $M539EPS $-1.2Operating Margin %-2,849.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.9Pre-tax Margin (%)-2,840.8Higher ROA y-yY
Price/Book7.810-y EBITDA Growth Rate %0Quick Ratio23.5Cash flow > EarningsY
Price/Sales5265-y EBITDA Growth Rate %0Current Ratio23.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-44.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-53.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M27.9ROI % (ttm)-59.8Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKJean-Marie Eveillard 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 22.29-34%Add 28.35%1,161,805
NLNKJean-Marie Eveillard 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 22.2925%Add 21.32%778,354
NLNKJean-Marie Eveillard 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 22.2942%Add 95.04%641,554
NLNKJean-Marie Eveillard 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 22.2984%New holding, 328939 sh.328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NLNK Jean-Marie Eveillard 2014-03-311,161,8054.170.09+28.35%
NLNK - PUTJean-Marie Eveillard 2014-03-313,2850.010
NLNK - CALLJean-Marie Eveillard 2014-03-316,8880.020.01
Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Link Charles J. Jr.Chairman of the Board and CEO 2014-07-08Sell20,000$26-14.27view
Ramsey William J.Quality Assurance Officer 2014-07-01Sell2,500$27.33-18.44view
Ramsey William J.Quality Assurance Officer 2014-06-06Sell66$2011.45view
Link Charles J. Jr.Chairman of the Board and CEO 2014-06-03Sell20,000$19.0616.95view
Ramsey William J.Quality Assurance Officer 2014-06-02Sell2,434$20.0411.23view
Link Charles J. Jr.Chairman of the Board and CEO 2014-05-02Sell20,000$21.264.84view
Ramsey William J.Quality Assurance Officer 2014-05-01Sell2,500$21.453.92view
Ramsey William J.Quality Assurance Officer 2014-04-08Sell2,500$24.11-7.55view
Link Charles J. Jr.Chairman of the Board and CEO 2014-04-02Sell20,000$28.1-20.68view
Link Charles J. Jr.Chairman of the Board and CEO 2014-03-05Sell20,000$38.88-42.67view

Press Releases about NLNK :

    Quarterly/Annual Reports about NLNK:

    News about NLNK:

    Articles On GuruFocus.com
    NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
    Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

    More From Other Websites
    NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 15 2014
    NewLink (NLNK) Shares March Higher, Can It Continue? Jul 02 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Jun 23 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Other Events Jun 02 2014
    NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting Jun 02 2014
    NewLink Genetics Presents Algenpantucel-L Clinical Data in Poster Discussion Session at ASCO 2014... Jun 02 2014
    Midday movers: Apple, Netflix, Lowe's & More May 30 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Other Events May 30 2014
    NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical... May 30 2014
    NewLink Genetics to Present at Jefferies 2014 Global Healthcare Conference May 29 2014
    NEWLINK GENETICS CORP Financials May 16 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Other Events May 15 2014
    NewLink Genetics to Present at the ASCO 2014 Annual Meeting May 15 2014
    NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report May 08 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 06 2014
    NewLink Genetics Corporation Reports First Quarter 2014 Financial Results May 06 2014
    NEWLINK GENETICS CORP Files SEC form 8-K, Other Events Apr 09 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide